Evidence Based Laboratory Medicine in the Diagnosis of Metabolic Syndrome.
作者信息
Stavljenić-Rukavin Ana, Pašalić Daria
机构信息
Zagreb University School of Medicine, Croatia.
出版信息
EJIFCC. 2007 Feb 26;18(1):47-54. eCollection 2007 Feb.
Abstract
摘要
相似文献
1
Evidence Based Laboratory Medicine in the Diagnosis of Metabolic Syndrome.循证检验医学在代谢综合征诊断中的应用
EJIFCC. 2007 Feb 26;18(1):47-54. eCollection 2007 Feb.
2
[Reference value for metabolic syndrome checkup and some problems].
Rinsho Byori. 2009 Sep;57(9):887-93.
3
Clinical and laboratory diagnosis of the metabolic syndrome.代谢综合征的临床与实验室诊断
J Clin Pathol. 2008 Jun;61(6):697-706. doi: 10.1136/jcp.2007.048363.
4
Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft).多囊卵巢综合征中西医结合诊断分类标准专家共识（草案）
J Integr Med. 2017 Mar;15(2):102-109. doi: 10.1016/S2095-4964(17)60331-5.
5
[Evidence-based laboratory medicine].[循证检验医学]
Orv Hetil. 2003 May 4;144(18):869-76.
6
Prevalence rates and costs of metabolic syndrome and associated risk factors using employees' integrated laboratory data and health care claims.利用员工综合实验室数据和医疗保健索赔数据评估代谢综合征及其相关危险因素的流行率和成本。
J Occup Environ Med. 2011 Jan;53(1):27-33. doi: 10.1097/JOM.0b013e3181ff0594.
7
[Laboratory markers of metabolic syndrome in clinical practice].[临床实践中代谢综合征的实验室指标]
Vnitr Lek. 2009 Jul-Aug;55(7-8):666-9.
8
Guidelines for the Laboratory Diagnosis of Middle East Respiratory Syndrome Coronavirus in Korea.韩国中东呼吸综合征冠状病毒实验室诊断指南
Infect Chemother. 2016 Mar;48(1):61-9. doi: 10.3947/ic.2016.48.1.61. Epub 2016 Mar 31.
9
Systematic reviews in laboratory medicine: principles, processes and practical considerations.检验医学中的系统评价：原则、流程及实际考量
Clin Chim Acta. 2004 Apr;342(1-2):23-39. doi: 10.1016/j.cccn.2003.12.015.
10
What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.运动与代谢异常之间的关系是什么？代谢综合征综述。
Sports Med. 2004;34(6):371-418. doi: 10.2165/00007256-200434060-00004.
本文引用的文献
1
A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.糖化血红蛋白（HbA1c）、空腹血糖和体重指数（BMI）相结合，对于筛查未来有2型糖尿病风险的个体是有效的：无需进行口服葡萄糖耐量试验（OGTT）。
J Intern Med. 2006 Sep;260(3):263-71. doi: 10.1111/j.1365-2796.2006.01689.x.
2
Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).糖化血红蛋白（HbA1c）用于预测法国男性和女性糖尿病进展情况：胰岛素抵抗综合征流行病学研究（DESIR）的数据
Diabetes Care. 2006 Jul;29(7):1619-25. doi: 10.2337/dc05-2525.
3
The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan.在日本，C反应蛋白作为代谢综合征可选组分的最佳切点。
Circ J. 2006 Apr;70(4):384-8. doi: 10.1253/circj.70.384.
4
Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.吡格列酮对非糖尿病代谢综合征患者脂蛋白、炎症标志物和脂肪因子的影响。
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. doi: 10.1161/01.ATV.0000195790.24531.4f. Epub 2005 Nov 10.
5
Inflammatory markers and the metabolic syndrome.
Atherosclerosis. 2005 Nov;183(1):187-8. doi: 10.1016/j.atherosclerosis.2005.06.029. Epub 2005 Jul 28.
6
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial.格列美脲与罗格列酮对接受二甲双胍治疗的代谢综合征患者非传统心血管危险因素的长期影响：一项随机、双盲临床试验
J Int Med Res. 2005 May-Jun;33(3):284-94. doi: 10.1177/147323000503300303.
7
The metabolic syndrome.代谢综合征
Lancet. 2005;365(9468):1415-28. doi: 10.1016/S0140-6736(05)66378-7.
8
Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome.代餐对于治疗具有代谢综合征特征的成年肥胖者，其效果与结构化减肥饮食相当。
J Nutr. 2004 Aug;134(8):1894-9. doi: 10.1093/jn/134.8.1894.
9
Use of metabolic markers to identify overweight individuals who are insulin resistant.使用代谢标志物来识别胰岛素抵抗的超重个体。
Ann Intern Med. 2003 Nov 18;139(10):802-9. doi: 10.7326/0003-4819-139-10-200311180-00007.
10
Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.吉非贝齐可降低患有代谢综合征致动脉粥样硬化血脂异常的腹型肥胖男性的血浆C反应蛋白水平。
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):702-3. doi: 10.1161/01.ATV.0000062990.62034.64.
Zotero 插件